International Journal of Chronic Obstructive Pulmonary Disease, 1176-9106

Journal

  1. 2020
  2. Ming, S. W. Y., Haughney, J., Ryan, D., Small, I., Lavorini, F., Papi, A., Singh, D., Halpin, D. M. G., Hurst, J. R., Patel, S., Ochel, M., Kocks, J., Carter, V., Hardjojo, A., & Price, D. B. (2020). A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD. International Journal of Chronic Obstructive Pulmonary Disease, 15, 3093-3103. https://doi.org/10.2147/COPD.S263745
  3. AIRFLOW-2 Trial Study Group, Valipour, A., Shah, P. L., Herth, F. J., Pison, C., Schumann, C., Hübner, R-H., Bonta, P. I., Kessler, R., Gesierich, W., Darwiche, K., Lamprecht, B., Perez, T., Skowasch, D., Deslee, G., Marceau, A., Sciurba, F. C., Gosens, R., Hartman, J. E., ... Slebos, D-J. (2020). Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2807-2816. https://doi.org/10.2147/COPD.S267409
  4. 2019
  5. Janssen, R., Wouters, E. F. M., Janssens, W., Daamen, W. F., Hagedoorn, P., de Wit, H. A. J. M., Serre, J., Gayan-Ramirez, G., Franssen, F. M. E., Reynaert, N. L., von der Thusen, J. H., & Frijlink, H. W. (2019). Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale. International Journal of Chronic Obstructive Pulmonary Disease, 14, 2587-2602. https://doi.org/10.2147/COPD.S228411
  6. PROactive Consortium, Boutou, A. K., Raste, Y., Demeyer, H., Troosters, T., Polkey, M. I., Vogiatzis, I., Louvaris, Z., Rabinovich, R. A., van der Molen, T., Garcia-Aymerich, J., & Hopkinson, N. S. (2019). Progression of physical inactivity in COPD patients: The effect of time and climate conditions - a multicenter prospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1979-1992. https://doi.org/10.2147/COPD.S208826
  7. 2018
  8. Valipour, A., Asadi, S., Pison, C., Jondot, M., Kessler, R., Benneddif, K., Deslee, G., Verdier, M., Slebos, D-J., & Mayse, M. (2018). Long-term safety of bilateral targeted lung denervation in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 2163-2172. https://doi.org/10.2147/COPD.S158748
  9. 2017
  10. Calverley, P. M., Eriksson, G., Jenkins, C. R., Anzueto, A. R., Make, B. J., Persson, A., Fageras, M., & Postma, D. S. (2017). Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease, 12, 13-25. https://doi.org/10.2147/COPD.S114209
  11. Hoogendoorn, M., Feenstra, T. L., Boland, M., Briggs, A. H., Borg, S., Jansson, S-A., Risebrough, N. A., Slejko, J. F., & Rutten-van Molken, M. P. M. H. (2017). Prediction models for exacerbations in different COPD patient populations: Comparing results of five large data sources. International Journal of Chronic Obstructive Pulmonary Disease, 12, 3183-3194. https://doi.org/10.2147/COPD.S142378
  12. Eriksson, G., Calverley, P. M., Jenkins, C. R., Anzueto, A. R., Make, B. J., Lindberg, M., Fageras, M., & Postma, D. S. (2017). The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials. International Journal of Chronic Obstructive Pulmonary Disease, 12, 1457-1468. https://doi.org/10.2147/COPD.S130713
  13. 2016
  14. Duenas-Espin, I., Demeyer, H., Gimeno-Santos, E., Polkey, M. I., Hopkinson, N. S., Rabinovich, R. A., Dobbels, F., Karlsson, N., Troosters, T., Garcia-Aymerich, J., & PROactive Consortium (2016). Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. International Journal of Chronic Obstructive Pulmonary Disease, 11, 1287-1294. https://doi.org/10.2147/COPD.S101459
  15. Pompe, E., de Jong, P. A., van Rikxoort, E. M., Estrella, L. G., de Jong, W. U., Vliegenthart, R., Oudkerk, M., van der Aalst, C. M., van Ginneken, B., Lammers, J-W. J., & Hoesein, F. A. A. M. (2016). Smokers with emphysema and small airway disease on computed tomography have lower bone density. International Journal of Chronic Obstructive Pulmonary Disease, 11, 1207-1216. https://doi.org/10.2147/COPD.S103680
  16. Muellerova, H., Landis, S. H., Aisanov, Z., Davis, K. J., Ichinose, M., Mannino, D. M., Maskell, J., Menezes, A. M., van der Molen, T., Oh, Y-M., Tabberer, M., & Han, M. K. (2016). Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. International Journal of Chronic Obstructive Pulmonary Disease, 11, 881-890. https://doi.org/10.2147/COPD.S102280
  17. 2015
  18. Make, B. J., Eriksson, G., Calverley, P. M., Jenkins, C. R., Postma, D. S., Peterson, S., Ostlund, O., & Anzueto, A. (2015). A score to predict short-term risk of COPD exacerbations (SCOPEX). International Journal of Chronic Obstructive Pulmonary Disease, 10, 201-209. https://doi.org/10.2147/COPD.S69589
  19. 2014
  20. Postma, D. S., Roche, N., Colice, G., Israel, E., Martin, R. J., van Aalderen, W. M. C., Grigg, J., Burden, A., Hillyer, E. V., von Ziegenweidt, J., Gopalan, G., & Price, D. (2014). Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 9, 1163-1186. https://doi.org/10.2147/COPD.S68289
  21. 2013
  22. 2012
  23. 2011
  24. 2010
  25. 2009
  26. 2008
Previous 1 2 Next

ID: 2351416